SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-018426
Filing Date
2024-05-09
Accepted
2024-05-09 16:05:46
Documents
36
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42858
2 ex99-1.htm EX-99.1 78494
3 ex99-2.htm EX-99.2 22430
4 ex99-2_001.jpg GRAPHIC 164099
5 ex99-2_002.jpg GRAPHIC 729352
6 ex99-2_003.jpg GRAPHIC 275637
7 ex99-2_004.jpg GRAPHIC 302672
8 ex99-2_005.jpg GRAPHIC 329301
9 ex99-2_006.jpg GRAPHIC 290663
10 ex99-2_007.jpg GRAPHIC 252957
11 ex99-2_008.jpg GRAPHIC 309552
12 ex99-2_009.jpg GRAPHIC 388072
13 ex99-2_010.jpg GRAPHIC 403588
14 ex99-2_011.jpg GRAPHIC 350194
15 ex99-2_012.jpg GRAPHIC 262980
16 ex99-2_013.jpg GRAPHIC 343560
17 ex99-2_014.jpg GRAPHIC 328467
18 ex99-2_015.jpg GRAPHIC 416290
19 ex99-2_016.jpg GRAPHIC 398807
20 ex99-2_017.jpg GRAPHIC 363437
21 ex99-2_018.jpg GRAPHIC 306702
22 ex99-2_019.jpg GRAPHIC 131742
23 ex99-1_001.jpg GRAPHIC 4671
24 image_001.jpg GRAPHIC 1135
  Complete submission text file 0001493152-24-018426.txt   9090859

Data Files

Seq Description Document Type Size
25 XBRL SCHEMA FILE ltrn-20240509.xsd EX-101.SCH 3030
26 XBRL LABEL FILE ltrn-20240509_lab.xml EX-101.LAB 34240
27 XBRL PRESENTATION FILE ltrn-20240509_pre.xml EX-101.PRE 22369
39 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3833
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 24930451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)